Anthem Biosciences Ltd
Ticker: ANTHEM
Decent
66/100
☆ Add to Watchlist
Investing Reference
Price
775.55
Market Cap
43555.67
Debt/Equity
0.0470
ROE %
20.821
PB
18.0739
Promoter %
74.690
Pledge %
0.000
1Y Rev Growth %
30.154
5Y Rev Growth %
24.187
NP Margin %
23.377
NP Margin 5Y Avg %
27.164
Trading Reference
1M Return %
-7.007
6M Return %
6.189
1Y Return %
6.189
% Away 52W High
12.630
% Away 52W Low
10.493
Daily Volume
426018
Investment Verdict
Hold
Score 68/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 35/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Anthem Biosciences Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If it breaks above the resistance level, there is a strong potential for upward momentum. However, if it falls below the support, it could face significant downside risk.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
V
Voltas Ltd
Voltas Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
B
Balkrishna Industries Ltd
Balkrishna Industries Ltd shows a decent investment potential with strong fundamentals, but caution is advised due to valuation concerns and execution risks.
View details
H
Hexaware Technologies Ltd
Hexaware Technologies has a decent outlook with growth potential, but faces challenges in profitability and valuation metrics.
View details
T
Tata Communications Ltd
Tata Communications Ltd shows potential for growth but faces challenges in profitability and execution risks. It is a decent investment but requires careful monitoring.
View details
C
Cochin Shipyard Ltd
Cochin Shipyard Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
D
Dalmia Bharat Ltd
Dalmia Bharat Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
L
L&T Technology Services Ltd
L&T Technology Services Ltd shows decent potential with a strong focus on digital transformation, but faces challenges in profitability and valuation compared to peers.
View details
H
Housing and Urban Development Corporation Ltd
The stock presents a decent investment opportunity but comes with notable risks and challenges.
View details
3
360 One Wam Ltd
360 One Wam Ltd shows a decent investment potential with consistent growth and a strong business model, but some risks in execution and valuation metrics should be considered.
View details
P
Procter & Gamble Hygiene and Health Care Ltd
The company shows potential for growth but faces challenges in profitability and valuation metrics. Investors should be cautious.
View details
C
Container Corporation of India Ltd
Container Corporation of India Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Investors should be cautious.
View details
J
Jubilant Foodworks Ltd
Jubilant Foodworks Ltd shows potential for growth but faces significant challenges in profitability and market competition.
View details
P
Petronet LNG Ltd
Petronet LNG Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
B
Bank of Maharashtra Ltd
Bank of Maharashtra Ltd shows decent fundamentals with moderate growth potential, but faces competitive and execution challenges.
View details
I
Indian Renewable Energy Development Agency Ltd
The stock has potential due to its position in the renewable energy sector, but faces challenges in execution and governance.
View details
G
Gujarat Fluorochemicals Ltd
Gujarat Fluorochemicals Ltd shows decent potential with consistent growth and profitability metrics, but some risks in governance and valuation should be monitored.
View details
Business Overview
Anthem Biosciences Ltd is a leading biotechnology company in India, specializing in providing high-quality research and development services. Catering primarily to pharmaceutical and biotechnology firms, Anthem plays a crucial role in accelerating drug discovery and development processes. With a commitment to innovation and excellence, the company is dedicated to enhancing the efficiency of biopharmaceutical research.
- Leading biotech firm in India
- Focus on drug discovery and development
- Serves pharmaceutical and biotech companies
- Commitment to innovation and quality
- Enhances research efficiency
- Strong track record in R&D services
Investment Thesis
Anthem Biosciences Ltd presents a strong investment case backed by a credible promoter group, robust growth in digital services, and attractive valuations compared to peers. This combination positions the company for sustainable growth and value appreciation in the burgeoning biotech sector.
- Strong promoter credibility enhances investor confidence.
- Significant growth potential in digital services segment.
- Attractive valuation metrics compared to industry peers.
- Strategic positioning in a rapidly evolving biotech landscape.
- Robust financial performance with consistent revenue growth.
Opportunity vs Risk
Opportunities
- Growing demand for biotech solutions
- Strong pipeline of innovative therapies
- Strategic partnerships with major firms
- Expansion into emerging markets
Risks ⚠️
- Regulatory hurdles in drug approvals
- High competition in biotech sector
- Dependency on successful clinical trials
- Market volatility affecting stock price
Peer Perspective
Anthem Biosciences Ltd trades at a discount compared to peers like Biocon and Syngene, primarily due to margin concerns. A sustained improvement in operational efficiency could trigger a rerating in its valuation.
Future Outlook
Anthem Biosciences Ltd is well-positioned for growth, driven by its innovative pipeline and expanding market presence; however, successful execution and effective cost control will be crucial to achieving its long-term objectives.
AI FAQs for Retail Users
- Q: What does Anthem Biosciences Ltd do?A: Anthem Biosciences Ltd focuses on biotechnology, developing innovative solutions for healthcare and pharmaceuticals.
- Q: Is Anthem Biosciences Ltd listed on stock exchanges?A: Yes, Anthem Biosciences Ltd is listed on major Indian stock exchanges.
- Q: What factors affect the stock price of Anthem Biosciences?A: Stock prices can be influenced by market trends, company performance, and industry developments.
- Q: How can I invest in Anthem Biosciences Ltd?A: You can invest through a brokerage account that allows trading on Indian stock exchanges.
- Q: What are the risks of investing in biotech stocks like Anthem?A: Biotech stocks can be volatile and may face regulatory, market, and operational risks.
📊 Stock Investment Checklist (100 Points)
Anthem Biosciences Ltd • Updated: 2025-09-17 09:48:11
-
10BusinessHighThe biotech sector is growing, but Anthem's competitive edge is unclear.
-
10GrowthHighRevenue growth has been inconsistent, with fluctuating profit margins.
-
10ProfitabilityHighROE and ROCE are below industry averages, with low operating cash flow.
-
8ValuationHighValuation metrics are higher than peers, indicating potential overvaluation.
-
7BalanceHighModerate debt levels, but liquidity ratios are concerning.
-
6GovernanceGoodPromoter holding is decent, but there are concerns over transparency.
-
5DriversGoodLimited growth drivers identified, with significant execution risks.
-
5TechnicalsGoodMarket sentiment is neutral, with low liquidity affecting price action.
Final Score & Verdict
Score 66 / 100
• Decent
Anthem Biosciences Ltd shows potential but faces challenges in growth consistency and profitability metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 75/100
- Profitability: 65/100
- Governance: 60/100
- Market Confidence: 68/100